BioSpace News Archive

Drug Development

FDA Approves Multiple Investigational New Drug Applications

This week, the U.S. Food and Drug Administration accepted Investigational New Drug Applications for multiple companies, clearing the way for clinical development.

November 3, 2021
·
4 min read
·
Alex Keown
Global Roundup: Singapore Researchers Create Atlas of Gastric Cancer

Biopharma and life sciences organizations from across the globe provide updates on their pipelines and businesses.

November 3, 2021
·
7 min read
·
Alex Keown
Biotech Beach

The Relaunch of Replicate

Replicate is relaunching—and here is everything you need to know about the start-up.

November 3, 2021
·
3 min read
·
Mishayl Hanan
Business

Clade and GRObio Land Series A Funds for Cancer, Protein Therapeutics

Clade Therapeutics will use its funds to further its research and development on cancer treatments, while GRO Biosciences will focus on chronic diseases.

November 3, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Amidst Controversy, CytoDyn Reports Early Leronlimab Data in NASH, Breast Cancer

CytoDyn announced two separate stories about its drug leronlimab today, one for nonalcoholic steatohepatitis and the other for metastatic triple-negative breast cancer.

November 3, 2021
·
4 min read
·
Mark Terry
Business

Flagship Pioneering is All Hands on Deck for Cystic Fibrosis

This first-of-its-kind collaboration will leverage the talent and innovation at companies such as Tessera Therapeutics to advance multiple candidates to human proof of concept.

November 3, 2021
·
3 min read
·
Heather McKenzie
Business

Harvard Bioscience Announces Third Quarter 2021 Financial Results

Harvard Bioscience, Inc. announced financial results for the period ended September 30, 2021.

November 3, 2021
·
13 min read
Genetown

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences - Nov 03, 2021

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced that the company will participate in the following investor conferences in November.

November 3, 2021
·
1 min read
Business

Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021

Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 9, 2021 at 8:30 a.m. ET to discuss financial results for the third quarter ended September 30, 2021.

November 3, 2021
·
1 min read
Genetown

Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy

Clade Therapeutics today announced it has secured an $87 million Series A financing led by Syncona Ltd. with participation from LifeSci Venture Partners, Emerson Collective and Bristol Myers Squibb.

November 3, 2021
·
5 min read